Edition:
India

DURECT Corp (DRRX.OQ)

DRRX.OQ on NASDAQ Stock Exchange Global Market

0.57USD
9:03pm IST
Change (% chg)

$0.00 (+0.78%)
Prev Close
$0.57
Open
$0.56
Day's High
$0.58
Day's Low
$0.56
Volume
5,789
Avg. Vol
109,094
52-wk High
$2.24
52-wk Low
$0.48

About

Durect Corporation is a biopharmaceutical company with research and development programs. The Company's products candidates include DUR-928, oral for metabolic/lipid disorders, and DUR-928, injectable for acute organ injuries. Its other product candidates include POSIMIR (controlled release injection of bupivacaine), REMOXY... (more)

Overall

Beta: 2.06
Market Cap(Mil.): $91.66
Shares Outstanding(Mil.): 162.06
Dividend: --
Yield (%): --

Financials

Earnings vs. Estimates